|
1
|
Pinard A, Jones GT and Milewicz DM:
Genetics of thoracic and abdominal aortic diseases. Circ Res.
124:588–606. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wanhainen A, Van Herzeele I, Bastos
Goncalves F, Bellmunt Montoya S, Berard X, Boyle JR, D'Oria M,
Prendes CF, Karkos CD, Kazimierczak A, et al: Editor's
choice-European society for vascular surgery (ESVS) 2024 clinical
practice guidelines on the management of abdominal aortoiliac
artery aneurysms. Eur J Vasc Endovasc Surg. 67:192–331. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Golledge J, Thanigaimani S, Powell JT and
Tsao PS: Pathogenesis and management of abdominal aortic aneurysm.
Eur Heart J. 44:2682–2697. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Golledge J: Abdominal aortic aneurysm:
Update on pathogenesis and medical treatments. Nat Rev Cardiol.
16:225–242. 2019. View Article : Google Scholar
|
|
5
|
Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H, Lu
HS and Zheng L: The mechanism and therapy of aortic aneurysms.
Signal Transduct Target Ther. 8:552023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rombouts KB, van Merrienboer TAR, Ket JCF,
Bogunovic N, van der Velden J and Yeung KK: The role of vascular
smooth muscle cells in the development of aortic aneurysms and
dissections. Eur J Clin Invest. 52:e136972022. View Article : Google Scholar :
|
|
7
|
Zhuge Y, Zhang J, Qian F, Wen Z, Niu C, Xu
K, Ji H, Rong X, Chu M and Jia C: Role of smooth muscle cells in
cardiovascular disease. Int J Biol Sci. 16:2741–2751. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frismantiene A, Philippova M, Erne P and
Resink TJ: Smooth muscle cell-driven vascular diseases and
molecular mechanisms of VSMC plasticity. Cell Signal. 52:48–64.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang HY, Chen AQ, Zhang H, Gao XF, Kong XQ
and Zhang JJ: Vascular smooth muscle cells phenotypic switching in
cardiovascular diseases. Cells. 11:40602022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang S, Liu D, Zhang X and Tian X:
Regulation of matrix metalloproteinase-2 and matrix
metalloproteinase-9 in abdominal aortic aneurysm. Cardiol Discov.
3:212–220. 2023.
|
|
12
|
Chen H: microRNA-based cancer diagnosis
and therapy. Int J Mol Sci. 25:2302023. View Article : Google Scholar
|
|
13
|
Bhaskaran M and Mohan M: MicroRNAs:
History, biogenesis, and their evolving role in animal development
and disease. Vet Pathol. 51:759–774. 2024. View Article : Google Scholar
|
|
14
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang G, Luo Y, Gao X, Liang Y, Yang F, Wu
J, Fang D and Luo M: MicroRNA regulation of phenotypic
transformations in vascular smooth muscle: Relevance to vascular
remodeling. Cell Mol Life Sci. 80:1442023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nguyen DND, Chilian WM, Zain SM, Daud MF
and Pung YF: MicroRNA regulation of vascular smooth muscle cells
and its significance in cardiovascular diseases. Can J Physiol
Pharmacol. 99:827–838. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maegdefessel L, Azuma J, Toh R, Merk DR,
Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ,
et al: Inhibition of microRNA-29b reduces murine abdominal aortic
aneurysm development. J Clin Invest. 122:497–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamasaki T, Horie T, Koyama S, Nakao T,
Baba O, Kimura M, Sowa N, Sakamoto K, Yamazaki K, Obika S, et al:
Inhibition of microRNA-33b specifically ameliorates abdominal
aortic aneurysm formation via suppression of inflammatory pathways.
Sci Rep. 12:119842022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maegdefessel L, Azuma J, Toh R, Deng A,
Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell
MV, et al: MicroRNA-21 blocks abdominal aortic aneurysm development
and nicotine-augmented expansion. Sci Transl Med. 4:122ra222012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maegdefessel L, Spin JM, Raaz U, Eken SM,
Toh R, Azuma J, Adam M, Nakagami F, Heymann HM, Chernogubova E, et
al: miR-24 limits aortic vascular inflammation and murine abdominal
aneurysm development. Nat Commun. 5:52142014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Wang Y, Bian X and Yin H:
MicroRNA-194 acts as a suppressor during abdominal aortic aneurysm
via inhibition of KDM3A-mediated BNIP3. Life Sci. 277:1193092021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma X, Yao H, Yang Y, Jin L, Wang Y, Wu L,
Yang S and Cheng K: miR-195 suppresses abdominal aortic aneurysm
through the TNF-α/NF-κB and VEGF/PI3K/Akt pathway. Int J Mol Med.
41:2350–2358. 2018.PubMed/NCBI
|
|
23
|
Li K, Zhang J, Zhang M, Wu Y, Lu X and Zhu
Y: miR-378a-5p inhibits the proliferation of colorectal cancer
cells by downregulating CDK1. World J Surg Oncol. 19:542021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nadeem U, Ye G, Salem M and Peng C:
MicroRNA-378a-5p targets cyclin G2 to inhibit fusion and
differentiation in BeWo cells. Biol Reprod. 91:762014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He Y, Shi Q, Ling Y, Guo H, Fei Y, Wu R,
Tang C, Zhang X and Yao L: ABLIM1, a novel ubiquitin E3 ligase,
promotes growth and metastasis of colorectal cancer through
targeting IĸBα ubiquitination and activating NF-ĸB signaling. Cell
Death Differ. 31:203–216. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu D, Wang X, Liu Y, Li C, Zhang Z and Lv
P: Actin-Binding LIM 1 (ABLIM1) inhibits glioblastoma progression
and serves as a novel prognostic biomarker. Dis Markers.
2022:95168082022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roof DJ, Hayes A, Adamian M, Chishti AH
and Li T: Molecular characterization of abLIM, a novel
actin-binding and double zinc finger protein. J Cell Biol.
138:575–588. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohsawa N, Koebis M, Mitsuhashi H, Nishino
I and Ishiura S: ABLIM1 splicing is abnormal in skeletal muscle of
patients with DM1 and regulated by MBNL, CELF and PTBP1. Genes
Cells. 20:121–134. 2015. View Article : Google Scholar
|
|
29
|
McDonald OG and Owens GK: Programming
smooth muscle plasticity with chromatin dynamics. Circ Res.
100:1428–1441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miralles F, Posern G, Zaromytidou AI and
Treisman R: Actin dynamics control SRF activity by regulation of
its coactivator MAL. Cell. 113:329–342. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cen B, Selvaraj A, Burgess RC, Hitzler JK,
Ma Z, Morris SW and Prywes R: Megakaryoblastic leukemia 1, a potent
transcriptional coactivator for serum response factor (SRF), is
required for serum induction of SRF target genes. Mol Cell Biol.
23:6597–6608. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Friedman RM, Truong HD, Aronson MR, Brown
EA, Angelozzi M, Chen JF, Zur KB, Lefebvre V and Gottardi R:
Inhibition of the MRTF-A/SRF signaling axis alleviates vocal fold
scarring. Matrix Biol. 137:1–11. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun Y, Boyd K, Xu W, Ma J, Jackson CW, Fu
A, Shillingford JM, Robinson GW, Hennighausen L, Hitzler JK, et al:
Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator
of mammary gland function. Mol Cell Biol. 26:5809–5826. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu H, Wang J, Bu Y, Li J, Li Y, Jing Q,
Wang X, Yan C, Liu D and Han Y: Pentamethylquercetin attenuates
angiotensin II-induced abdominal aortic aneurysm formation by
blocking nuclear translocation of C/EBPβ at Lys253. Biochim Biophys
Acta Mol Basis Dis. 1870:1672242024. View Article : Google Scholar
|
|
35
|
Yang L, Sui HG, Wang MM, Li JY, He XF, Li
JY and Wang XZ: MiR-30c-1-3p targets matrix metalloproteinase 9
involved in the rupture of abdominal aortic aneurysms. J Mol Med
(Berl). 100:1209–1221. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
37
|
Wen Y, Liu Y, Li Q, Tan J, Fu X, Liang Y,
Tuo Y, Liu L, Zhou X, LiuFu D, et al: Spatiotemporal ATF3
expression determines VSMC fate in abdominal aortic aneurysm. Circ
Res. 134:1495–1511. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tastsoglou S, Skoufos G, Miliotis M,
Karagkouni D, Koutsoukos I, Karavangeli A, Kardaras FS and
Hatzigeorgiou AG: DIANA-miRPath v4.0: Expanding target-based miRNA
functional analysis in cell-type and tissue contexts. Nucleic Acids
Res. 51:W154–W159. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu Y, Cai Z and He B: Smooth muscle
heterogeneity and plasticity in health and aortic aneurysmal
disease. Int J Mol Sci. 24:117012023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao G, Zhao Y, Lu H, Chang Z, Liu H, Wang
H, Liang W, Liu Y, Zhu T, Rom O, et al: BAF60c prevents abdominal
aortic aneurysm formation through epigenetic control of vascular
smooth muscle cell homeostasis. J Clin Invest. 132:e1583092022.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen M, Yang D, Zhou Y, Yang C, Lin W, Li
J, Liu J, Ye J, Huang W, Ma W, et al: Colchicine blocks abdominal
aortic aneurysm development by maintaining vascular smooth muscle
cell homeostasis. Int J Biol Sci. 20:2092–2110. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nappi F: Current opinion in acute aortic
dissection. Cardiol Discov. Jan 3–2025.Epub ahead of print.
|
|
43
|
Lu H, Du W, Ren L, Hamblin MH, Becker RC,
Chen YE and Fan Y: Vascular smooth muscle cells in aortic aneurysm:
From genetics to mechanisms. J Am Heart Assoc. 10:e0236012021.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Petsophonsakul P, Furmanik M, Forsythe R,
Dweck M, Schurink GW, Natour E, Reutelingsperger C, Jacobs M, Mees
B and Schurgers L: Role of vascular smooth muscle cell phenotypic
switching and calcification in aortic aneurysm formation.
Arterioscler Thromb Vasc Biol. 39:1351–1368. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ailawadi G, Moehle CW, Pei H, Walton SP,
Yang Z, Kron IL, Lau CL and Owens GK: Smooth muscle phenotypic
modulation is an early event in aortic aneurysms. J Thorac
Cardiovasc Surg. 138:1392–1399. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li X, Yang Y, Wang Z, Jiang S, Meng Y,
Song X, Zhao L, Zou L, Li M and Yu T: Targeting non-coding RNAs in
unstable atherosclerotic plaques: Mechanism, regulation,
possibilities, and limitations. Int J Biol Sci. 17:3413–3427. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou Y, Wang M, Zhang J, Xu P and Wang H:
MicroRNA-29a-3p regulates abdominal aortic aneurysm development and
progression via direct interaction with PTEN. J Cell Physiol.
235:9414–9423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shi X, Ma W, Li Y, Wang H, Pan S, Tian Y,
Xu C and Li L: MiR-144-5p limits experimental abdominal aortic
aneurysm formation by mitigating M1 macrophage-associated
inflammation: Suppression of TLR2 and OLR1. J Mol Cell Cardiol.
143:1–14. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Machado IF, Teodoro JS, Palmeira CM and
Rolo AP: miR-378a: A new emerging microRNA in metabolism. Cell Mol
Life Sci. 77:1947–1958. 2020. View Article : Google Scholar
|
|
50
|
Pan X, Zhao L, Quan J, Liu K, Lai Y, Li Z,
Zhang Z, Xu J, Xu W, Guan X, et al: MiR-378a-5p acts as a tumor
suppressor in renal cell carcinoma and is associated with the good
prognosis of patients. Am J Transl Res. 11:2207–2218.
2019.PubMed/NCBI
|
|
51
|
Zhang Y, Zhang P and Deng C: miR-378a-5p
regulates CAMKK2/AMPK pathway to contribute to cerebral
ischemia/reperfusion injury-induced neuronal apoptosis. Folia
Histochem Cytobiol. 59:57–65. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sha T, Li J, Sun S, Li J, Zhao X, Li Z and
Cui Z: YEATS domain-containing 2 (YEATS2), targeted by microRNA
miR-378a-5p, regulates growth and metastasis in head and neck
squamous cell carcinoma. Bioengineered. 12:7286–7296. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bhandari R, Shaikh II, Bhandari R and
Chapagain S: LINC01023 promotes the hepatoblastoma tumorigenesis
via miR-378a-5p/WNT3 axis. Mol Cell Biochem. 478:1867–1885. 2023.
View Article : Google Scholar
|
|
54
|
Yan C and Jin Y: Silencing of long
noncoding RNA MIAT inhibits the viability and proliferation of
breast cancer cells by promoting miR-378a-5p expression. Open Med
(Wars). 18:202306762023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu S, Yang Y, Jiang S, Xu H, Tang N, Lobo
A, Zhang R, Liu S, Yu T and Xin H: MiR-378a-5p regulates
proliferation and migration in vascular smooth muscle cell by
targeting CDK1. Front Genet. 10:222019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Narahara H, Sakai E, Yamaguchi Y, Narahara
S, Iwatake M, Okamoto K, Yoshida N and Tsukuba T: Actin binding LIM
1 (abLIM1) negatively controls osteoclastogenesis by regulating
cell migration and fusion. J Cell Physiol. 234:486–499. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Koshelev M, Sarma S, Price RE, Wehrens XH
and Cooper TA: Heart-specific overexpression of CUGBP1 reproduces
functional and molecular abnormalities of myotonic dystrophy type
1. Hum Mol Genet. 19:1066–1075. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang S, Liu C, Guo Y, Li G, Li D, Yan X
and Zhu X: Self-construction of actin networks through phase
separation-induced abLIM1 condensates. Proc Natl Acad Sci USA.
119:e21224201192022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li G, Huang S, Yang S, Wang J, Cao J,
Czajkowsky DM, Shao Z and Zhu X: abLIM1 constructs non-erythroid
cortical actin networks to prevent mechanical tension-induced
blebbing. Cell Discov. 4:422018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhou J, Zhang M, Fang H, El-Mounayri O,
Rodenberg JM, Imbalzano AN and Herring BP: The SWI/SNF chromatin
remodeling complex regulates myocardin-induced smooth
muscle-specific gene expression. Arterioscler Thromb Vasc Biol.
29:921–928. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang DZ, Li S, Hockemeyer D, Sutherland L,
Wang Z, Schratt G, Richardson JA, Nordheim A and Olson EN:
Potentiation of serum response factor activity by a family of
myocardin-related transcription factors. Proc Natl Acad Sci USA.
99:14855–14860. 2002. View Article : Google Scholar : PubMed/NCBI
|
